Ambien vs Trazodone for Insomnia: How They Compare
Here is a fact that surprises many patients: trazodone, one of the most widely prescribed sleep medicines in the United States, has never been approved by the FDA to treat insomnia. Its only approved use is major depressive disorder. Ambien (zolpidem), by contrast, was developed, tested and approved specifically as a sleep medicine. So when people search Ambien vs trazodone, they are comparing a purpose-built hypnotic with an antidepressant used “off-label” for sleep. That gap between paperwork and everyday practice is the thread running through this whole comparison.
Harvard Health has described zolpidem and trazodone as the two most commonly prescribed sleep medications in the U.S., with zolpidem prescribing falling while trazodone’s has risen. Understanding why requires looking at how each drug works, what the evidence says, how each is regulated, and what kinds of risks come with each. This article does that, with a focus on the questions patients and caregivers raise most. For a short primer on zolpidem itself, see our overview of Ambien’s uses.
In one paragraph: Ambien is an FDA-approved, Schedule IV sleep medicine that acts on GABA-A receptors and carries a boxed warning for complex sleep behaviors. Trazodone is an antidepressant, not a controlled substance, often given at low doses for sleep without FDA approval for that use. The American Academy of Sleep Medicine’s 2017 guideline suggests zolpidem for insomnia and suggests against trazodone, though trazodone may still make sense for some people, particularly when depression is also present. Each has a distinct set of risks, and the right choice depends on the individual.
“Off-Label” Explained: What It Means and Why It Happens
When a drug is FDA-approved, it’s approved for specific conditions based on clinical trial evidence submitted by the manufacturer. Doctors in the U.S. are legally allowed to prescribe an approved drug for other purposes, which is called off-label use. Off-label prescribing is common and isn’t automatically unsafe or improper. It does mean the evidence supporting that particular use hasn’t gone through the same formal FDA review.
Trazodone was approved in 1981 to treat depression, at daily doses well above what is usually used for sleep. At lower doses, its sedating side effect is strong enough that clinicians began using it as a sleep aid. A study presented at the American Psychiatric Association’s 2022 meeting, drawing on U.S. primary care claims data, found that about 40% of trazodone prescriptions in that dataset went to patients with an insomnia diagnosis, mostly at doses below 150 mg a day.
Why would prescribers choose an off-label antidepressant over an approved sleep medicine? The reasons commonly given include:
- Trazodone is not a controlled substance, so there are no federal refill limits and fewer concerns about misuse.
- It is inexpensive as a generic.
- It does not carry the FDA’s 2019 boxed warning about complex sleep behaviors.
- Many people with insomnia also have depression or anxiety, and a sedating antidepressant can feel like a fit for both.
Those are real practical advantages. But practical advantages are not the same as proof that a drug improves sleep, which brings us to the guideline.
Two Very Different Mechanisms
Zolpidem: turning up the brain’s “brake”
Zolpidem is a non-benzodiazepine hypnotic, often called a “Z-drug.” It binds to a specific site on the GABA-A receptor and boosts the effect of GABA, the brain’s main calming chemical. The result is fast-onset sleepiness. Immediate-release zolpidem reaches peak levels in about an hour and a half and has an average half-life of roughly two and a half hours, according to its FDA label. Its action is narrow and its job is single-purpose: bring on sleep.
Trazodone: several receptors at once
Trazodone belongs to a class sometimes called serotonin antagonist and reuptake inhibitors (SARIs). According to the NIH StatPearls review of trazodone, it blocks serotonin type 2 receptors and inhibits serotonin reuptake. It also blocks histamine H1 receptors (the same target as many sedating antihistamines) and alpha-1 adrenergic receptors (which help regulate blood pressure). At lower doses, the sleepiness it causes is thought to come mostly from the 5-HT2A, histamine and alpha-1 blockade rather than its antidepressant action.
This “several receptors at once” profile explains both its appeal and its drawbacks. The antihistamine effect causes drowsiness. The alpha-1 blockade can lower blood pressure when you stand up. The serotonin effects open the door to interactions with other serotonin-affecting medicines. StatPearls lists a half-life of roughly 5 to 9 hours, considerably longer than zolpidem’s, which helps explain why some people feel groggy the next morning.
What the AASM 2017 Guideline Says About Each
In 2017 the American Academy of Sleep Medicine published its clinical practice guideline on drug treatment for chronic insomnia in adults. The panel reviewed randomized trials and rated each medicine for sleep-onset insomnia (trouble falling asleep) and sleep-maintenance insomnia (trouble staying asleep). The AASM’s guideline summary shows:
- Zolpidem: suggested for both sleep-onset and sleep-maintenance insomnia (a weak recommendation).
- Trazodone: suggested against for both sleep-onset and sleep-maintenance insomnia (also a weak recommendation). It appears in the guideline’s group of medicines not recommended for insomnia, alongside diphenhydramine, melatonin, tiagabine, tryptophan and valerian.
“Weak” here is a technical term. It means the panel judged the balance of benefit and harm as uncertain enough that many patients could reasonably choose differently. It doesn’t mean trazodone never helps anyone, or that zolpidem works for everyone. Coverage of the guideline in Psychiatric News noted that sedating antidepressants such as trazodone may still be appropriate for patients with psychiatric conditions, with the final call left to the treating clinician. The guideline also emphasized that cognitive behavioral therapy for insomnia (CBT-I) should be the primary treatment for chronic insomnia, with medicines as a second step or temporary support.
Ambien vs Trazodone: Evidence and Regulation Side by Side
| Question | Ambien (zolpidem) | Trazodone |
|---|---|---|
| FDA-approved indication | Short-term treatment of insomnia marked by difficulty falling asleep | Major depressive disorder in adults |
| Approved for insomnia? | Yes | No (off-label use) |
| AASM 2017 position for chronic insomnia | Suggested for sleep onset and maintenance (weak) | Suggested against for sleep onset and maintenance (weak) |
| DEA controlled substance? | Yes, Schedule IV | No |
| Boxed warning | Complex sleep behaviors (added 2019) | Suicidal thoughts and behaviors in children and young adults (shared by antidepressants) |
| Approximate half-life | About 2.5 hours (immediate release) | About 5 to 9 hours |
| Label guidance on food | Not with or immediately after a meal | Take shortly after a meal or light snack |
| Brand status (U.S.) | Brand Ambien and generics available | Former brands (Desyrel, Oleptro) no longer marketed; generics widely available |
Notice the boxed warning row. Both drugs carry the FDA’s strongest kind of warning, but for very different reasons. That matters when people describe trazodone as the “safer” option: it is safer in some ways and riskier in others.
Side-Effect Profiles: Different Drugs, Different Worries
Trazodone’s risks to know about
The current trazodone prescribing information on DailyMed lists a range of warnings. Most come from studies at antidepressant doses, but several still matter at lower doses:
- Next-day grogginess and impaired coordination. Drowsiness was the most common complaint in trials, and the label warns about impaired thinking and motor skills. Its longer half-life means sleepiness can carry into the morning.
- Orthostatic hypotension. Because of alpha-1 blockade, blood pressure can drop when standing up, causing dizziness or fainting. StatPearls notes higher risk in older adults and people with heart conditions, and that this effect tends to appear in the first week.
- Heart rhythm problems. Trazodone can prolong the QT interval on an ECG, which in rare cases can lead to dangerous arrhythmias. People with heart disease or those on other QT-prolonging drugs need particular caution.
- Priapism. A painful erection lasting several hours is rare but is a medical emergency. MedlinePlus lists an erection lasting more than 6 hours as a reason to seek help immediately.
- Serotonin syndrome. Combining trazodone with other serotonin-affecting drugs (many antidepressants, triptans, some pain medicines, certain supplements) can raise the risk of this potentially life-threatening reaction. It must not be taken with or within 14 days of an MAOI.
- Bleeding risk, low sodium and angle-closure glaucoma are additional label warnings.
- Discontinuation symptoms. Stopping abruptly can cause nausea, dizziness, irritability and trouble sleeping, so the label advises gradual reduction under medical guidance.
Zolpidem’s risks to know about
- Complex sleep behaviors. In 2019 the FDA added a boxed warning after reports of serious injuries and deaths from sleepwalking, sleep-driving and other activities done while not fully awake. People who have had such an episode should not be prescribed zolpidem again. See our detailed guide to Ambien and complex sleep behaviors.
- Anterograde amnesia. People may not remember events after taking a dose, especially if they stay up instead of going to bed. We cover this in Ambien and memory loss.
- Next-day impairment. The label warns that driving can be affected the next morning, particularly with less than 7 to 8 hours in bed, higher doses, or in women, who clear the drug more slowly.
- Falls and confusion, especially in older adults.
- Dangerous interactions with alcohol, opioids and other sedatives, which can deepen sedation and slow breathing.
Harvard Health makes a useful point here: trazodone does not cause the risky sleep behaviors linked to zolpidem, but it brings its own problems, including drowsiness, confusion and falls. Neither drug is risk-free, and “less dramatic” risks aren’t automatically smaller ones.
Controlled vs Non-Controlled: Dependence and Misuse
This is one of the clearest differences between the two.
Zolpidem is a Schedule IV controlled substance under federal law. That classification reflects a recognized potential for misuse and physical dependence. With regular nightly use, some people develop tolerance (the same dose feels less effective), and stopping suddenly can bring rebound insomnia or withdrawal symptoms. Our guides to Ambien tolerance and dependence and Ambien withdrawal and tapering cover what that looks like and why stopping should be planned with a prescriber.
Trazodone is not a controlled substance, and its label reports no drug-seeking behavior in clinical studies. That said, “not controlled” doesn’t mean “nothing happens when you stop.” Like other antidepressants, trazodone can cause discontinuation symptoms if stopped abruptly, and the label recommends tapering when possible.
If you are worried about how you’re using any sleep medicine, or you find yourself taking more than prescribed, you can reach the SAMHSA National Helpline at 1-800-662-4357. It’s free, confidential and available 24 hours a day.
When Depression or Anxiety Is Part of the Picture
Insomnia rarely travels alone. Trouble sleeping is both a symptom of depression and a risk factor for it, and anxiety frequently keeps people awake. This overlap is the main reason trazodone shows up so often in sleep prescriptions, and it’s also where the comparison becomes most individual.
A few points worth understanding:
- Treating the root matters. If depression is driving the insomnia, a sleep medicine alone may mask a symptom without treating the condition. The Ambien label itself says that insomnia that doesn’t improve after 7 to 10 days may point to an underlying psychiatric or medical illness.
- Low-dose trazodone isn’t an antidepressant dose. The doses usually used for sleep are below the range used to treat depression. If depression needs treatment, your prescriber will consider that separately.
- Zolpidem and mood. The zolpidem label warns that worsening depression, including suicidal thoughts, has been reported in people with depression taking sleep medicines. This doesn’t rule it out, but it calls for close follow-up.
- Trazodone’s boxed warning concerns suicidal thoughts in children, teens and young adults during antidepressant treatment. Families should watch for mood changes, especially early on and after dose changes.
- Anxiety medicines add complexity. Combining zolpidem with benzodiazepines adds sedation. Our article on Ambien vs Xanax for sleep explains why these aren’t interchangeable. For non-drug coping during acute anxiety, see how to calm an anxiety attack.
If you or someone you care about is having thoughts of suicide or self-harm, call or text 988 (the 988 Suicide & Crisis Lifeline in the U.S.), or contact local emergency services right away.
Day-to-Day Differences: Timing, Food and the Morning After
Beyond evidence and regulation, the Ambien vs trazodone comparison also plays out in small daily routines that patients notice quickly.
Timing at night. Zolpidem’s label says to take it right before bed and only when you can stay in bed for at least 7 to 8 hours. Because it acts quickly, staying up after a dose (finishing chores, scrolling, answering messages) raises the chance of memory gaps and odd behavior. Trazodone’s sedation builds more gradually and lasts longer, so prescribers often discuss what time of evening to take it so that the drowsiness lines up with bedtime rather than spilling into the morning.
Food. Here the two labels point in opposite directions. Ambien’s patient instructions say not to take it with or immediately after a meal, because food slows how fast it starts working. Trazodone’s label says to take it shortly after a meal or light snack. If you’ve been prescribed one after using the other, it’s easy to carry over the wrong habit, so confirm with your pharmacist.
The next morning. Both can affect alertness, but in different ways. With zolpidem, the main concern is impaired driving and reaction time, especially after a short night or in women. With trazodone, people more often describe a heavy, slow feeling or lightheadedness when getting out of bed, linked to its longer half-life and blood-pressure effects. Standing up slowly and sitting on the edge of the bed for a moment can help, and any persistent grogginess should go back to the prescriber. Our guide to next-day drowsiness and driving explains why feeling awake isn’t the same as being fully alert.
Alcohol. Neither drug mixes safely with alcohol. Both labels warn about added sedation, and with zolpidem, alcohol also raises the risk of complex sleep behaviors.
Older Adults: Both Need Caution
For people 65 and older, the American Geriatrics Society’s 2023 Beers Criteria list Z-drugs such as zolpidem among medicines to generally avoid, citing falls, fractures and confusion. Trazodone isn’t automatically the safe alternative, however. Its blood-pressure-lowering effect and next-day sedation can also contribute to falls, and StatPearls notes that orthostatic hypotension is more likely in older patients. Our guide to Ambien for older adults covers fall-prevention steps that apply no matter which medicine is used.
Ambien vs Trazodone: Pros and Cons
| Ambien (zolpidem) | Trazodone |
|---|---|
| Pro: FDA-approved for insomnia, with trial evidence for faster sleep onset | Pro: Not a controlled substance; no federal refill limits |
| Pro: AASM suggests it for both falling and staying asleep | Pro: Inexpensive and widely available as a generic |
| Pro: Short half-life, so effects usually fade by morning when taken as labeled | Pro: No boxed warning for complex sleep behaviors |
| Pro: Several forms exist for different patterns (immediate, extended, sublingual) | Pro: May fit when depression is also being treated, at the prescriber’s judgment |
| Con: Schedule IV; tolerance, dependence and withdrawal are possible | Con: Not FDA-approved for insomnia; AASM suggests against it for insomnia |
| Con: Boxed warning for sleepwalking, sleep-driving and similar behaviors | Con: Longer half-life can mean morning grogginess |
| Con: Memory gaps and next-day driving impairment are possible | Con: Dizziness on standing, rare heart rhythm effects, rare priapism |
| Con: Dangerous with alcohol, opioids and other sedatives | Con: Serotonin syndrome risk with other serotonin-affecting drugs; MAOI interaction |
If your prescriber is considering a different Z-drug instead of zolpidem, our comparison of Ambien vs Sonata looks at how a shorter-acting option fits different insomnia patterns.
Can Trazodone and Ambien Be Used Together?
Some people are prescribed both, usually when trazodone is part of depression treatment and a short-term sleep medicine is added. Whether that’s appropriate is strictly a prescriber decision. Taken together, the two drugs add sedation, which can increase the risk of falls, confusion, impaired driving and memory gaps. A prescriber weighing this will consider your age, other medicines, alcohol use, breathing issues such as sleep apnea, and how each drug has affected you on its own.
Please don’t combine them, add one to the other, or swap one for the other on your own, even if you have both at home. If you’re already taking both and are unsure why, ask your prescriber or pharmacist to walk you through the plan.
Bringing It to Your Appointment
Because the “right” answer depends so much on context, a few targeted questions can make the visit more productive:
- Is my insomnia mainly trouble falling asleep, staying asleep, or both, and how does that affect the choice?
- Could depression, anxiety, pain or a breathing problem be driving my sleep trouble?
- If you’re recommending trazodone, is it for sleep alone or also for mood, and why this dose?
- If you’re recommending zolpidem, how long should I expect to take it, and how will we review it?
- Have you considered CBT-I for me, and where can I access it?
- Do any of my current medicines or supplements interact with these drugs?
- What symptoms should make me call you right away?
Common Questions About Ambien and Trazodone
Is trazodone safer than Ambien for sleep?
It’s safer in some respects (no controlled status, no complex-sleep-behavior boxed warning) and riskier in others (blood pressure drops, heart rhythm effects, priapism, serotonin interactions, longer-lasting grogginess). Which profile is safer depends on your health, age and other medicines.
Why do doctors prescribe trazodone for sleep if it isn’t approved for insomnia?
Off-label prescribing is legal and common. Clinicians often cite its low cost, lack of controlled-substance status, and usefulness when depression is also present. The AASM guideline, however, suggests against it for insomnia because of limited supporting evidence.
Is trazodone addictive like Ambien?
Trazodone isn’t a controlled substance, and its label reports no drug-seeking behavior in studies. It can still cause discontinuation symptoms if stopped suddenly. Zolpidem is Schedule IV and can lead to tolerance and dependence.
Why does trazodone make me groggy in the morning?
Its half-life is several hours longer than zolpidem’s, so some of the drug may still be active when you wake. Grogginess is worth reporting to your prescriber rather than adjusting the dose yourself.
Can I switch from Ambien to trazodone on my own?
No. Stopping zolpidem suddenly can cause rebound insomnia or withdrawal, and trazodone has its own interactions and starting considerations. Any switch should be planned with your prescriber.
References
- American Academy of Sleep Medicine. Pharmacologic Treatment of Chronic Insomnia in Adults: Guideline at a Glance (2017).
- Psychiatric News. AASM releases guideline on pharmacologic treatment for insomnia.
- NIH StatPearls. Trazodone.
- DailyMed. Trazodone hydrochloride tablets, prescribing information.
- MedlinePlus. Trazodone.
- U.S. FDA. Certain prescription insomnia medicines: new boxed warning (2019).
- Harvard Health Publishing. A popular alternative to a traditional sleeping pill.
- FDA prescribing information for Ambien (zolpidem tartrate); American Geriatrics Society 2023 Beers Criteria.
The information on this page is meant to help you understand your options, not to direct your treatment. It does not replace a conversation with a physician, psychiatrist or pharmacist who can review your full medical history, mental health and current medicines. Decisions about starting, stopping, combining or changing zolpidem or trazodone should be made only with the clinician who prescribes them. If you experience a medical emergency, call 911 or your local emergency number.

